
Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Disease Pathology, Therapeutic Applications, Application, End-use - Global Forecast 2024-20
Description
Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Disease Pathology, Therapeutic Applications, Application, End-use - Global Forecast 2024-2030
The Neurovascular Intervention Devices Market size was estimated at USD 3.75 billion in 2023 and expected to reach USD 3.95 billion in 2024, at a CAGR 6.47% to reach USD 5.83 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Intervention Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Boston Scientific Corporation, Evasc Medical Systems Corp., Johnson & Johnson Services, Inc., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Microport Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, and Terumo Corporation.
Market Segmentation & Coverage
This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Balloon Systems
Carotid Stents
Catheters
Embolic Coils
Embolic Protection Devices
Flow Diverters
Guidewires
Intracranial Stents
Intrasaccular Devices
Neurothrombectomy Devices
Stent Retrievers
Process
Carotid Endarterectomy
Cerebral Angiography
Coiling
Flow Diversion
Microsurgical Clipping
Neurothrombectomy
Stenting
Disease Pathology
Arteriovenous Malformations & Fistulas
Carotid Artery Stenosis
Cerebral Aneuryms
Ischemic Strokes
Therapeutic Applications
Brain Aneurysm
Ischemic Strokes
Stenosis
Application
Arteriovenous Malformation
Intracranial Aneurysm
Ischemic Stroke
End-use
Ambulatory Surgical Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Neurovascular Intervention Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Intervention Devices Market?
3. What are the technology trends and regulatory frameworks in the Neurovascular Intervention Devices Market?
4. What is the market share of the leading vendors in the Neurovascular Intervention Devices Market?
5. Which modes and strategic moves are suitable for entering the Neurovascular Intervention Devices Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
180 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Neurovascular Intervention Devices Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising demand for effective neurovascular devices
- 5.1.1.2. Government initiatives to modernize and expand healthcare infrastructure across emerging markets
- 5.1.1.3. Improvements in medical reimbursement in mature economies
- 5.1.2. Restraints
- 5.1.2.1. Stringent regulatory scenario associated with neurovascular intervention devices
- 5.1.3. Opportunities
- 5.1.3.1. Rising number of researches in the field of neurovascular therapies
- 5.1.3.2. Growing awareness among neurosurgeons about minimally invasive surgical procedures
- 5.1.4. Challenges
- 5.1.4.1. Lack of skilled neurosurgeons
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Neurovascular Intervention Devices Market, by Product
- 6.1. Introduction
- 6.2. Balloon Systems
- 6.3. Carotid Stents
- 6.4. Catheters
- 6.5. Embolic Coils
- 6.6. Embolic Protection Devices
- 6.7. Flow Diverters
- 6.8. Guidewires
- 6.9. Intracranial Stents
- 6.10. Intrasaccular Devices
- 6.11. Neurothrombectomy Devices
- 6.12. Stent Retrievers
- 7. Neurovascular Intervention Devices Market, by Process
- 7.1. Introduction
- 7.2. Carotid Endarterectomy
- 7.3. Cerebral Angiography
- 7.4. Coiling
- 7.5. Flow Diversion
- 7.6. Microsurgical Clipping
- 7.7. Neurothrombectomy
- 7.8. Stenting
- 8. Neurovascular Intervention Devices Market, by Disease Pathology
- 8.1. Introduction
- 8.2. Arteriovenous Malformations & Fistulas
- 8.3. Carotid Artery Stenosis
- 8.4. Cerebral Aneuryms
- 8.5. Ischemic Strokes
- 9. Neurovascular Intervention Devices Market, by Therapeutic Applications
- 9.1. Introduction
- 9.2. Brain Aneurysm
- 9.3. Ischemic Strokes
- 9.4. Stenosis
- 10. Neurovascular Intervention Devices Market, by Application
- 10.1. Introduction
- 10.2. Arteriovenous Malformation
- 10.3. Intracranial Aneurysm
- 10.4. Ischemic Stroke
- 11. Neurovascular Intervention Devices Market, by End-use
- 11.1. Introduction
- 11.2. Ambulatory Surgical Centers
- 11.3. Hospitals
- 12. Americas Neurovascular Intervention Devices Market
- 12.1. Introduction
- 12.2. Argentina
- 12.3. Brazil
- 12.4. Canada
- 12.5. Mexico
- 12.6. United States
- 13. Asia-Pacific Neurovascular Intervention Devices Market
- 13.1. Introduction
- 13.2. Australia
- 13.3. China
- 13.4. India
- 13.5. Indonesia
- 13.6. Japan
- 13.7. Malaysia
- 13.8. Philippines
- 13.9. Singapore
- 13.10. South Korea
- 13.11. Taiwan
- 13.12. Thailand
- 13.13. Vietnam
- 14. Europe, Middle East & Africa Neurovascular Intervention Devices Market
- 14.1. Introduction
- 14.2. Denmark
- 14.3. Egypt
- 14.4. Finland
- 14.5. France
- 14.6. Germany
- 14.7. Israel
- 14.8. Italy
- 14.9. Netherlands
- 14.10. Nigeria
- 14.11. Norway
- 14.12. Poland
- 14.13. Qatar
- 14.14. Russia
- 14.15. Saudi Arabia
- 14.16. South Africa
- 14.17. Spain
- 14.18. Sweden
- 14.19. Switzerland
- 14.20. Turkey
- 14.21. United Arab Emirates
- 14.22. United Kingdom
- 15. Competitive Landscape
- 15.1. FPNV Positioning Matrix
- 15.2. Market Share Analysis, By Key Player
- 15.3. Competitive Scenario Analysis, By Key Player
- 16. Competitive Portfolio
- 16.1. Key Company Profiles
- 16.1.1. Abbott Laboratories
- 16.1.2. Acandis GmbH
- 16.1.3. Boston Scientific Corporation
- 16.1.4. Evasc Medical Systems Corp.
- 16.1.5. Johnson & Johnson Services, Inc.
- 16.1.6. LivaNova PLC
- 16.1.7. Medikit Co., Ltd.
- 16.1.8. Medtronic PLC
- 16.1.9. Microport Scientific Corporation
- 16.1.10. Penumbra, Inc.
- 16.1.11. Phenox GmbH
- 16.1.12. Rapid Medical Ltd.
- 16.1.13. Stryker Corporation
- 16.1.14. Terumo Corporation
- 16.2. Key Product Portfolio
- 17. Appendix
- 17.1. Discussion Guide
- 17.2. License & Pricing
- FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
- FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
- FIGURE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
- FIGURE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
- FIGURE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
- FIGURE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
- FIGURE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.